Epithelial Ovarian Cancer

specific

An invasive carcinoma that arises from the surface ovarian epithelium. The vast majority of cases are adenocarcinomas. The most common sites of involvement are the contralateral ovary, peritoneal cavity, para-aortic and pelvic lymph nodes, and liver. Lung and pleura are the most common sites of extra-abdominal spread. The primary form of therapy is surgical. The overall prognosis of ovarian carcinoma remains poor, a direct result of its rapid growth rate and the lack of early symptoms.

72

Centers

89

Active Trials

$68M

Cancer Funding

Top Centers for Epithelial Ovarian Cancer(72)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
81.6
2
NCI Comprehensive
High-Volume Research Center
79.8
3
NCI Comprehensive
High-Volume Research Center
76.1
4
NCI Comprehensive
High-Volume Research Center
75.6
5
NCI Comprehensive
High-Volume Research Center
73.0
6
High-Volume Research Center
72.4
7
High-Volume Research Center
72.0
8
NCI Comprehensive
High-Volume Research Center
71.1
9
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
High-Volume Research Center
70.8
10
NCI Comprehensive
High-Volume Research Center
70.5
11
Stephenson Cancer CenterOklahoma City, OK
NCI Clinical
High-Volume Research Center
70.3
12
NCI Comprehensive
High-Volume Research Center
70.0
13
NCI Comprehensive
Active Research Program
68.5
14
NCI Comprehensive
Active Research Program
67.5
15
NCI Comprehensive
Active Research Program
65.4
16
Active Research Program
64.4
17
NCI Comprehensive
Active Research Program
63.1
18
Active Research Program
63.1
19
NCI Comprehensive
Active Research Program
62.7
20
Active Research Program
61.2
21
Active Research Program
61.2
22
NCI Clinical
Active Research Program
60.2
23
NCI Comprehensive
Active Research Program
58.4
24
Active Research Program
58.4
25
NCI Comprehensive
Active Research Program
56.8
26
NCI Comprehensive
Active Research Program
53.9
27
NCI Comprehensive
Active Research Program
53.8
28
NCI Clinical
Active Research Program
53.8
29
Active Research Program
53.8
30
BC CancerVancouver, BC
Active Research Program
53.8
31
NCI Basic_laboratory
Active Research Program
53.4
32
NCI Comprehensive
Active Research Program
52.4
33
NCI Comprehensive
Active Research Program
50.0
34
NCI Comprehensive
Active Research Program
49.5
35
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
49.0
36
NCI Comprehensive
Active Research Program
48.5
37
NCI Comprehensive
Active Research Program
48.0
38
Active Research Program
46.6
3945.1
40
NCI Comprehensive
Active Research Program
44.7
41
NCI Comprehensive
Active Research Program
44.7
42
NCI Comprehensive
Active Research Program
44.7
43
NCI Comprehensive
Active Research Program
44.7
44
NCI Comprehensive
Active Research Program
44.7
45
NCI Comprehensive
Active Research Program
44.7
46
NCI Comprehensive
Active Research Program
44.7
4744.7
48
Active Research Program
44.7
49
Active Research Program
44.7
50
Active Research Program
44.7
51
Active Research Program
44.7
52
Active Research Program
44.7
53
Active Research Program
44.1
5443.2
55
NCI Comprehensive
Active Research Program
42.2
56
Active Research Program
39.8
57
NCI Comprehensive
Active Research Program
39.3
58
Active Research Program
38.8
59
NCI Comprehensive
Active Research Program
38.3
6029.1
6129.1
6229.1
6329.1
64
NCI Clinical
29.1
65
Cedars-Sinai CancerLos Angeles, CA
29.1
6629.1
6729.1
6829.1
6929.1
70
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
29.1
7129.1
7229.1

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →